Correction to: Development of a novel TLR8 agonist for cancer immunotherapy
Mol Biomed
.
2021 May 21;2(1):16.
doi: 10.1186/s43556-021-00042-3.
Authors
Yuxun Wang
1
,
Heping Yang
2
,
Huanping Li
2
,
Shuda Zhao
2
,
Yikun Zeng
2
,
Panpan Zhang
2
,
Xiaoqin Lin
2
,
Xiaoxiang Sun
2
,
Longsheng Wang
2
,
Guangliang Fu
2
,
Yaqiao Gao
2
,
Pei Wang
2
,
Daxin Gao
2
Affiliations
1
Shanghai Denovo Pharmatech Co., Ltd., 576 Libing Road, Shanghai Zhangjiang High-Tech Park, Pudong New District, Shanghai, 201203, China. yuxun_wang@yahoo.com.
2
Shanghai Denovo Pharmatech Co., Ltd., 576 Libing Road, Shanghai Zhangjiang High-Tech Park, Pudong New District, Shanghai, 201203, China.
PMID:
35006462
PMCID:
PMC8607363
DOI:
10.1186/s43556-021-00042-3
No abstract available
Publication types
Published Erratum